OAM
HCAT icon

Oppenheimer Asset Management’s Health Catalyst HCAT Stock Holding History

Oppenheimer Asset Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8,464
Closed -$221K – 1178
2022
Q1 		$221K Sell
8,464
-94
-1% -$2.67K ﹤0.01% 1104
2021
Q4 		$339K Sell
8,558
-78
-0.9% -$3.56K ﹤0.01% 1050
2021
Q3 		$432K Buy
8,636
+104
+1% +$5.67K 0.01% 971
2021
Q2 		$474K Sell
8,532
-441
-5% -$23.5K 0.01% 977
2021
Q1 		$420K Sell
8,973
-834
-9% -$40.4K 0.01% 961
2020
Q4 		$427K Buy
9,807
+155
+2% +$5.72K 0.01% 904
2020
Q3 		$353K Buy
+9,652
New +$328K 0.01% 897

Other funds holding HCAT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return